Biotech stocks led Monday's top gainers, with ImmunityBio Inc. standing out. The stock market saw positive trends after President Trump's tax reprieve on tech companies. IBRX attracted investor interest with its immune-enhancing therapies for cancer and infectious diseases, announcing updates and global expansion plans.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing